Schedule 13G ownership disclosure
TG THERAPEUTICS INC COM
Security class unavailable · CUSIP: 88322Q108
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 14,746,392
- Percent of class
- 10.1500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-107554
- Form type
- SC 13G
- Filer
- TG THERAPEUTICS, INC.
- CIK
- CIK 1001316
- Filed
- Oct 11, 2022
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership